Elisabeth Seja

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

Antoni Ribas, Luis H. Camacho, Gabriel Lopez‐Berestein et al. · Journal of Clinical Oncology · 2005 · 584 citations

Medicine, Oncology, Pharmacology +17

A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides

Lisa H. Butterfield, Antoni Ribas, Vivian B. Dissette et al. · Clinical Cancer Research · 2006 · 230 citations

Life Sciences, Immunology, Oncology +17

T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.

Lisa H. Butterfield, Antoni Ribas, Wilson S. Meng et al. · PubMed · 2003 · 163 citations

Life Sciences, Immunology, Oncology +17

Role of Dendritic Cell Phenotype, Determinant Spreading, and Negative Costimulatory Blockade in Dendritic Cell-Based Melanoma Immunotherapy

Antoni Ribas, John A. Glaspy, Yohan Lee et al. · Journal of Immunotherapy · 2004 · 120 citations

Medicine, Immunology, Oncology +17

Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma

Begoña Comı́n-Anduix, Yohan Lee, Jason Jalil et al. · Journal of Translational Medicine · 2008 · 81 citations · Full text

Life Sciences, Immunology, Oncology +17